USP39 and endometrial carcinoma: In addition, in the phenotypic studies of head and neck squamous cell carcinoma, leukemia, endometrial carcinoma, and non-small cell lung cancer, the relatively small number of tumor tissue specimens may limit a comprehensive evaluation of USP39 expression levels and its heterogeneity across different tumor types.